Table 32a continued
Summary of Residue Data - Non-formula-fed Veal
2006 Domestic Monitoring Plan
----------------- Amount Found in Sample ------------- No Quantitation
Number Viol- Units 0.01- 0.11- 0.21-0.31- 0.51-1.01-2.51- Over Viol- Not Vio-
Residue Tissue Samplesations None 0.10 0.20 0.30 0.50 1.00 2.50 5.00 5.00 ative lative
Sulfamethiazole Liver 165 0 ppm 165 0 0 0 0 0 0 0 0 0 0
Sulfanilamide Liver 165 0 ppm 165 0 0 0 0 0 0 0 0 0 0
Sulfapyridine Liver 165 0 ppm 165 0 0 0 0 0 0 0 0 0 0
Sulfadiazine Liver 165 0 ppm 165 0 0 0 0 0 0 0 0 0 0
Sulfadoxine Liver 165 0 ppm 165 0 0 0 0 0 0 0 0 0 0
Sulfamethaxazole Liver 165 0 ppm 165 0 0 0 0 0 0 0 0 0 0
Ivermectin Liver 173 1 ppb 167 0 0 0 0 0 0 0 6 0 0
Phenylbutazone Kidney 165 0 ppb 165 0 0 0 0 0 0 0 0 0 0
Doramectin Liver 173 0 ppb 172 0 0 0 0 0 0 0 1 0 0
Moxidectin Liver 173 0 ppb 170 0 0 0 0 0 0 0 3 0 0
Table 32b
Summary of Residue Data by Compound Class - Non-formula-fed Veal
2006 Domestic Monitoring Plan
Percent Upper 95%
Residue Compound Samples Samples Violative Confidence
or Compound Class Tested Violative Samples Limit
Antibiotics 200 6 3 3.8
Avermectins 173 1 0.6 2.7
Chlorinated Hydrocarbons 203 0 0 1.5
Chlorinated Organophosphates 203 0 0 1.5
beta Agonists 175 1 0.6 2.7
Phenylbutazone 165 0 0 1.8
Sulfonamides 165 0 0 1.8
Ractopamine 201 0 0 1.5
Florfenicol 78 2 2.6 7.8
Trenbolone 174 2 1.1 3.6
Total 1737 12
52